PL2768942T3 - Dostarczanie dokomórkowe - Google Patents

Dostarczanie dokomórkowe

Info

Publication number
PL2768942T3
PL2768942T3 PL12841329T PL12841329T PL2768942T3 PL 2768942 T3 PL2768942 T3 PL 2768942T3 PL 12841329 T PL12841329 T PL 12841329T PL 12841329 T PL12841329 T PL 12841329T PL 2768942 T3 PL2768942 T3 PL 2768942T3
Authority
PL
Poland
Prior art keywords
intracellular delivery
intracellular
delivery
Prior art date
Application number
PL12841329T
Other languages
English (en)
Inventor
Armon Sharei
Andrea Adamo
Robert Langer
Klavs F. Jensen
Original Assignee
Massachusetts Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute Of Technology filed Critical Massachusetts Institute Of Technology
Publication of PL2768942T3 publication Critical patent/PL2768942T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C12M1/02—Apparatus for enzymology or microbiology with agitation means; with heat exchange means
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/16—Microfluidic devices; Capillary tubes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04—Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Electromagnetism (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Saccharide Compounds (AREA)
PL12841329T 2011-10-17 2012-10-17 Dostarczanie dokomórkowe PL2768942T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161548013P 2011-10-17 2011-10-17
US201261684301P 2012-08-17 2012-08-17
PCT/US2012/060646 WO2013059343A1 (en) 2011-10-17 2012-10-17 Intracellular delivery
EP12841329.1A EP2768942B1 (en) 2011-10-17 2012-10-17 Intracellular delivery

Publications (1)

Publication Number Publication Date
PL2768942T3 true PL2768942T3 (pl) 2020-05-18

Family

ID=48141314

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12841329T PL2768942T3 (pl) 2011-10-17 2012-10-17 Dostarczanie dokomórkowe

Country Status (19)

Country Link
US (3) US10696944B2 (pl)
EP (2) EP2768942B1 (pl)
JP (2) JP6219832B2 (pl)
KR (1) KR102058568B1 (pl)
CN (3) CN113337402B (pl)
AU (1) AU2012326203B2 (pl)
BR (1) BR112014009346B1 (pl)
CA (1) CA2852672C (pl)
DK (1) DK2768942T3 (pl)
ES (1) ES2764105T3 (pl)
HR (1) HRP20200051T1 (pl)
HU (1) HUE047507T2 (pl)
LT (1) LT2768942T (pl)
PL (1) PL2768942T3 (pl)
PT (1) PT2768942T (pl)
RS (1) RS59898B1 (pl)
RU (1) RU2656156C2 (pl)
SI (1) SI2768942T1 (pl)
WO (1) WO2013059343A1 (pl)

Families Citing this family (194)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2764105T3 (es) 2011-10-17 2020-06-02 Massachusetts Inst Technology Administración intracelular
US11046596B2 (en) 2012-10-25 2021-06-29 Hydrus Technology Pty. Ltd. Electrochemical liquid treatment apparatus
US9725709B2 (en) * 2013-03-12 2017-08-08 OpenCell Technologies, Inc. Intracellular delivery and transfection methods and devices
GB201308946D0 (en) * 2013-05-16 2013-07-03 The Technology Partnership Plc Method and device
ITPD20130220A1 (it) * 2013-08-02 2015-02-03 Univ Padova Metodo per la riprogrammazione e programmazione cellulare mediante l'impiego di tecnologia microfluidica
SG10201801188XA (en) 2013-08-16 2018-03-28 Massachusetts Inst Technology Selective delivery of material to cells
EP3071515A2 (en) 2013-11-18 2016-09-28 Rubius Therapeutics, Inc. Synthetic membrane-receiver complexes
EP3583946A1 (en) 2014-04-01 2019-12-25 Rubius Therapeutics, Inc. Enucleated hematopoietic cells comprising an exogenous antigen
CN106660836B (zh) 2014-05-23 2020-12-15 海卓斯科技有限公司 电化学处理方法
US11046595B2 (en) 2014-05-23 2021-06-29 Hydrus Technology Pty. Ltd. Electrochemical treatment methods
EP3164482B1 (en) 2014-07-03 2024-05-22 Massachusetts Institute of Technology Apparatus and method for optimization of cell electroporation
US10081816B1 (en) 2014-07-03 2018-09-25 Nant Holdings Ip, Llc Mechanical transfection devices and methods
US10760040B1 (en) 2014-07-03 2020-09-01 NanoCav, LLC Mechanical transfection devices and methods
RU2739794C2 (ru) * 2014-10-31 2020-12-28 Массачусетс Инститьют Оф Текнолоджи Доставка биомолекул в клетки иммунной системы
JP6846345B2 (ja) * 2014-11-14 2021-03-24 マサチューセッツ インスティテュート オブ テクノロジー 破壊及び場による細胞への化合物及び組成物の送達
EP3037515A1 (en) * 2014-12-28 2016-06-29 Femtofab Co., Ltd. Modified cell prepared by putting material into the cell without using delivery vehicle
KR20160079661A (ko) * 2014-12-28 2016-07-06 주식회사 펨토펩 운반체의 사용 없이 세포에 물질을 주입하여 변환시킨 세포
EP3037517A1 (en) * 2014-12-28 2016-06-29 Femtofab Co., Ltd. Process for modifying a cell by putting material into the cell
EP3037518B1 (en) * 2014-12-28 2020-05-06 Femtobiomed Inc. Device for putting material into cell
HK1247241A1 (zh) * 2015-01-07 2018-09-21 英迪公司 一种用於机械和水动力微流体转染的方法以及用於其的设备
AU2016206870B2 (en) * 2015-01-12 2022-02-17 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
ES2880473T5 (es) * 2015-01-30 2024-05-09 Univ California Suministro de proteínas en células hematopoyéticas primarias
WO2016168680A1 (en) * 2015-04-17 2016-10-20 Exocyte Therapeutics Pte Ltd. Method for developing exosome-based vaccines
AU2016289530B2 (en) * 2015-07-09 2021-05-06 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
PL3325081T3 (pl) * 2015-07-24 2021-12-20 Sorrento Therapeutics, Inc. Sposoby dostarczania limfatycznego środków czynnych
CA2991455C (en) * 2015-07-24 2023-10-10 Kimberly-Clark Worldwide, Inc. Methods for better delivery of active agents to tumors
CN105384825B (zh) 2015-08-11 2018-06-01 南京传奇生物科技有限公司 一种基于单域抗体的双特异性嵌合抗原受体及其应用
US11286454B2 (en) 2015-08-31 2022-03-29 I Peace, Inc. Pluripotent stem cell manufacturing system and method for producing induced pluripotent stem cells
JP7046795B2 (ja) 2015-09-04 2022-04-04 スクイーズ バイオテクノロジーズ カンパニー 細孔を有する表面によって媒介される生体分子の細胞内送達
WO2017041051A1 (en) 2015-09-04 2017-03-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
US20180327706A1 (en) * 2015-10-19 2018-11-15 The Methodist Hospital Crispr-cas9 delivery to hard-to-transfect cells via membrane deformation
US20190010495A1 (en) 2015-12-28 2019-01-10 Novartis Ag Compositions and methods for the treatment of hemoglobinopathies
CN108779475A (zh) * 2016-01-12 2018-11-09 Sqz生物技术公司 复合物的细胞内递送
WO2017172981A2 (en) 2016-03-29 2017-10-05 University Of Southern California Chimeric antigen receptors targeting cancer
US20190275520A1 (en) * 2016-03-31 2019-09-12 Massachusetts Institute Of Technology Flow-through microfluidic methods and devices featuring membrane-perturbing surface interactions for intracellular delivery
WO2017176764A1 (en) * 2016-04-04 2017-10-12 CyteQuest, Inc. System, device and method for electroporation of cells
WO2017179064A1 (en) * 2016-04-11 2017-10-19 Indian Institute Of Technology, Bombay Microdevice for separating plasma from human blood
RU2770492C2 (ru) * 2016-05-03 2022-04-18 ЭсКьюЗед БАЙОТЕКНОЛОДЖИЗ КОМПАНИ Внутриклеточная доставка биологических молекул для индуцирования толерантности
RU2747878C2 (ru) * 2016-05-03 2021-05-17 ЭсКьюЗед БАЙОТЕКНОЛОДЖИЗ КОМПАНИ Внутриклеточная доставка биомолекул для индукции толерантности
WO2017201378A1 (en) * 2016-05-19 2017-11-23 University Of Rochester Micro-slits for reticulocyte maturation
WO2017210334A1 (en) * 2016-05-31 2017-12-07 Massachusetts Institute Of Technology Hydrodynamically controlled electric fields for high throughput transformation & high throughput parallel transformation platform
EP3463664A1 (en) * 2016-06-06 2019-04-10 The Charles Stark Draper Laboratory, Inc. Systems and methods for cell transduction
KR102512934B1 (ko) 2016-08-10 2023-03-23 레전드 바이오테크 아일랜드 리미티드 Bcma를 표적으로 하는 키메라 항원 수용체 및 이들의 이용 방법
WO2018039084A1 (en) 2016-08-20 2018-03-01 The Regents Of The University Of California High-throughput system and method for the temporary permeablization of cells
WO2018047149A1 (en) * 2016-09-12 2018-03-15 Texas Children's Hospital Cell filtration as a means of introducing exogenous material into a cell
CA3039406A1 (en) 2016-09-19 2018-03-22 University Of Southern California Non-radioactive cytotoxicity assays
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
WO2018074980A1 (en) * 2016-10-21 2018-04-26 Agency For Science, Technology And Research Device, system and method for intracellular delivery of substances
WO2018089497A1 (en) * 2016-11-08 2018-05-17 Georgia Tech Research Corporation Methods for convectively-driven intracellular delivery
US10011848B2 (en) 2016-11-09 2018-07-03 City University Of Hong Kong System and method for delivery of substance into mammalian cells
US11332713B2 (en) 2016-11-16 2022-05-17 KSQ Therapeutics, Inc. Gene-regulating compositions and methods for improved immunotherapy
CN106525273B (zh) * 2016-11-24 2018-10-30 哈尔滨工业大学 基于量子点薄膜的细胞温度传感器及其制备方法
JP7685735B2 (ja) 2016-12-02 2025-05-30 アンヘレス セラピューティクス インコーポレイテッド 合成免疫受容体およびその使用方法
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
GB201701946D0 (en) * 2017-02-06 2017-03-22 Univ Leeds Innovations Ltd Fluid flow device
CA3088495A1 (en) 2017-02-13 2018-08-16 The Regents Of The University Of California Device and method for intracellular delivery of biomolecular cargo via acoustic wave exposure
WO2019103857A1 (en) 2017-11-22 2019-05-31 Iovance Biotherapeutics, Inc. Expansion of peripheral blood lymphocytes (pbls) from peripheral blood
KR20200043369A (ko) * 2017-06-16 2020-04-27 님 싸이언티픽 인코포레이티드 나노 니들 및 관련된 기기 및 방법
CN111032134B (zh) * 2017-06-30 2024-02-13 阿维塔斯有限公司 电喷雾导管
BR112020005938A2 (pt) 2017-09-27 2020-11-17 University Of Southern California célula imune ou população de células imunes da mesma, célula efetora imune ou célula-tronco, célula que apresenta antígeno, polinucleotídeo recombinante, vetor, composição que compreende uma célula imune efetora ou uma célula-tronco, métodos para produzir uma célula efetora imune que expressa receptor imune de ocorrência não natural, para gerar uma população de células manipuladas por rna, para fornecer imunidade antidoença em um indivíduo, para tratar ou prevenir uma doença associada à expressão de um antígeno, e, uso
WO2019084410A1 (en) * 2017-10-26 2019-05-02 Repligen Corporation MICRO-ALTERNATIVE TANGENTIALLY FLOWING INFUSION FILTER, TREATMENT CONTAINER, AND METHODS OF USING THE SAME
US20190175506A1 (en) 2017-11-17 2019-06-13 Codiak Biosciences, Inc. Loading of Extracellular Vesicles through Imparting of Mechanical Shear
CN111601883B (zh) 2017-11-17 2024-06-21 艾欧凡斯生物治疗公司 由细针抽吸物和小活检物扩增til
JP2021507689A (ja) 2017-12-05 2021-02-25 スクイーズ バイオテクノロジーズ カンパニー 抗体産生をモジュレートするための生体分子の細胞内送達
US11365390B2 (en) 2017-12-19 2022-06-21 Xcell Biosciences, Inc. Methods of modulating cell phenotype by way of regulating the gaseous environment
JP2021506309A (ja) * 2017-12-20 2021-02-22 スクイーズ バイオテクノロジーズ カンパニー 細胞の中へのペイロードの送達のためのシステム
US11713446B2 (en) 2018-01-08 2023-08-01 Iovance Biotherapeutics, Inc. Processes for generating TIL products enriched for tumor antigen-specific T-cells
KR102956273B1 (ko) 2018-01-08 2026-04-24 이오반스 바이오테라퓨틱스, 인크. 종양 항원-특이적 t-세포에 대해 풍부화된 til 생성물의 생성 방법
WO2019136459A1 (en) 2018-01-08 2019-07-11 Iovance Biotherapeutics, Inc. Processes for generating til products enriched for tumor antigen-specific t-cells
WO2019148184A2 (en) 2018-01-29 2019-08-01 The Regents Of The University Of California Guided magnetic nanostructures for targeted and high-throughput intracellular delivery
CA3091439A1 (en) 2018-02-21 2019-08-29 Nemametrix Inc. Transgenic animal phenotyping platform and uses thereof
JP7595827B2 (ja) * 2018-03-12 2024-12-09 ステムセル テクノロジーズ カナダ インコーポレーテッド 免疫応答を改変するための生体分子の細胞内送達
MA52003A (fr) 2018-03-12 2021-01-20 Sqz Biotechnologies Co Procédés de traitement de maladies associées au hpv
JP2019154314A (ja) * 2018-03-13 2019-09-19 国立大学法人九州大学 キャピラリーチップ及びこれを備える装置、並びに細胞への外来物質の導入方法
US20190284553A1 (en) 2018-03-15 2019-09-19 KSQ Therapeutics, Inc. Gene-regulating compositions and methods for improved immunotherapy
WO2019178420A1 (en) 2018-03-15 2019-09-19 KSQ Therapeutics, Inc. Gene-regulating compositions and methods for improved immunotherapy
WO2019195620A1 (en) * 2018-04-04 2019-10-10 The General Hospital Corporation Microfluidic systems and methods to denude mammalian oocytes
EP3556845A1 (en) 2018-04-20 2019-10-23 Cellix Limited A method and device for transfecting cells
US11904081B2 (en) 2018-05-11 2024-02-20 Lupagen, Inc. Systems and methods for closed loop, real-time modifications of patient cells
CA3101510A1 (en) 2018-06-01 2019-12-05 University Of Southern California Diverse antigen binding domains, novel platforms and other enhancements for cellular therapy
US11654434B2 (en) 2018-06-24 2023-05-23 Nemametrix Inc. Microinjection chip, device, system and uses thereof for unicellular or multicellular organisms
US12440839B2 (en) * 2018-08-21 2025-10-14 The Regents Of The University Of California High-throughput system and method for the temporary permeabilization of cells using lipid bilayers
WO2020052542A1 (en) 2018-09-10 2020-03-19 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies against cll1 and constructs thereof
US20210388390A1 (en) 2018-10-04 2021-12-16 Sqz Biotechnologies Company Intracellular delivery of biomolecules to enhance antigen presenting cell function
JP2022509497A (ja) * 2018-10-26 2022-01-20 カイトペン コーポレイション 電気穿孔のためのデバイス、システム、及びキット、ならびにそれらの使用方法
CA3118493A1 (en) 2018-11-05 2020-05-14 Iovance Biotherapeutics, Inc. Expansion of tils utilizing akt pathway inhibitors
TW202039829A (zh) 2018-11-05 2020-11-01 美商艾歐凡斯生物治療公司 改善之腫瘤反應性ｔ細胞的選擇
CR20210295A (es) 2018-11-05 2021-07-09 Iovance Biotherapeutics Inc Procesos para la producción de linfocitos infiltrantes de tumor y usos de estos en inmunoterapia
TW202039831A (zh) 2018-11-05 2020-11-01 美商艾歐凡斯生物治療公司 對抗ｐｄ－１抗體呈現難治性之非小細胞肺癌（ｎｓｃｌｃ）病患之治療
US10731012B2 (en) * 2018-11-06 2020-08-04 President And Fellows Of Harvard College Anti-clogging microfluidic multichannel device
KR102232757B1 (ko) * 2018-11-22 2021-03-26 (주)엑솔런스바이오테크놀로지 체외충격파를 이용한 표적물질 전달 장치
WO2020117856A1 (en) * 2018-12-04 2020-06-11 Cellfe, Inc. Methods and systems for intracellular delivery
WO2020131547A1 (en) 2018-12-19 2020-06-25 Iovance Biotherapeutics, Inc. Methods of expanding tumor infiltrating lymphocytes using engineered cytokine receptor pairs and uses thereof
WO2020154696A1 (en) 2019-01-25 2020-07-30 Sqz Biotechnologies Company Anucleate cell-derived vaccines
JP7610773B2 (ja) 2019-02-28 2025-01-09 ステムセル テクノロジーズ カナダ インコーポレーテッド 免疫応答を改変するためのｐｂｍｃへの生体分子の送達
JP7810554B2 (ja) 2019-03-01 2026-02-03 アケロイス バイオファーマ， インコーポレイテッド 抗原特異的免疫細胞におけるｃｄ１６０機能をモジュレートする方法およびその使用
KR20210136050A (ko) 2019-03-01 2021-11-16 이오반스 바이오테라퓨틱스, 인크. 액상 종양으로부터의 종양 침윤 림프구의 확장 및 그의 치료 용도
CN113840657B (zh) * 2019-03-12 2023-04-14 明新特生物科技公司 用于材料的细胞内输送的微流体系统及其方法
KR102354673B1 (ko) 2019-03-12 2022-01-25 고려대학교 산학협력단 관성을 기반으로 한 세포 내 전달 미세 유체 플랫폼
CN113631575A (zh) 2019-03-15 2021-11-09 笛卡尔疗法股份有限公司 抗bcma嵌合抗原受体
KR20210149791A (ko) * 2019-04-08 2021-12-09 에스큐지 바이오테크놀로지스 컴퍼니 페이로드를 세포 내로 전달하기 위한 시스템에서 이용하기 위한 카트리지
US12465912B2 (en) 2019-04-11 2025-11-11 The Chinese University Of Hong Kong Systems and methods for controlled membrane disruption
WO2020232029A1 (en) 2019-05-13 2020-11-19 Iovance Biotherapeutics, Inc. Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
US20220213422A1 (en) * 2019-05-15 2022-07-07 Cellfe, Inc. Methods and systems for intracellular delivery and products thereof
WO2020252215A1 (en) * 2019-06-12 2020-12-17 Cellfe, Inc. Methods and systems for cell labeling and imaging
CN120665955A (zh) 2019-06-25 2025-09-19 伊纳瑞农业技术有限公司 改善的同源依赖修复基因组编辑
CN110272810A (zh) * 2019-07-01 2019-09-24 广州世赛生物科技有限公司 外源物质递送至真核细胞内的装置和方法及其应用
AU2020299541A1 (en) * 2019-07-02 2022-01-27 Kytopen Corporation Devices, systems, and kits for electro-mechanical delivery and methods of use thereof
US11746354B2 (en) 2019-07-19 2023-09-05 Inari Agriculture Technology, Inc. Homology dependent repair genome editing
KR102483442B1 (ko) * 2019-11-06 2022-12-30 고려대학교 산학협력단 액적 기반 미세유체 세포내 물질전달 방법 및 플랫폼
KR102499546B1 (ko) * 2020-10-07 2023-02-14 고려대학교 산학협력단 액적 변형에 기반한 세포내 물질 전달방법 및 이를 위한 칩
AU2020380721B2 (en) * 2019-11-06 2023-11-09 Korea University Research And Business Foundation Droplet deformation-based method of transferring material into cells and chip for same
WO2021118990A1 (en) 2019-12-11 2021-06-17 Iovance Biotherapeutics, Inc. Processes for the production of tumor infiltrating lymphocytes (tils) and methods of using the same
WO2021123920A1 (en) 2019-12-18 2021-06-24 Novartis Ag Compositions and methods for the treatment of hemoglobinopathies
EP4592310A2 (en) 2020-03-16 2025-07-30 Angeles Therapeutics, Inc. Novel antigen binding domains and synthetic antigen receptors incorporating the same
US20230105923A1 (en) * 2020-03-26 2023-04-06 Agency For Science, Technology And Research A method and system for introducing one or more exogenous substances into an immune cell
WO2021194497A1 (en) * 2020-03-26 2021-09-30 Hewlett-Packard Development Company, L.P. Cell preparation with a series of detection devices
EP4146793A1 (en) 2020-05-04 2023-03-15 Iovance Biotherapeutics, Inc. Selection of improved tumor reactive t-cells
CA3176826A1 (en) 2020-05-04 2021-11-11 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
JP2023524277A (ja) * 2020-05-05 2023-06-09 スリーディー システムズ インコーポレーテッド マイクロコズムバイオスキャフォールドおよびその利用
CA3177288A1 (en) 2020-05-11 2021-11-18 F.Hoffmann-La Roche Ag Combination therapy with modified pbmcs and an immunoconjugate
WO2021237164A1 (en) * 2020-05-22 2021-11-25 Sqz Biotechnologies Company Point of care system for automatically processing cells
CA3180301A1 (en) * 2020-05-26 2021-12-02 Otto J. Prohaska Devices and methods for transfection
WO2022012680A1 (en) 2020-07-16 2022-01-20 Nanjing Legend Biotech Co., Ltd. Cd20 binding molecules and uses thereof
EP4188425B1 (en) 2020-07-29 2025-05-14 Stemcell Technologies Canada Inc. Methods to stimulate immune responses to mutant ras using anucleate cells
WO2022026620A1 (en) 2020-07-29 2022-02-03 Sqz Biotechnologies Company Methods to stimulate immune responses to mutant ras using nucleated cells
CN112268934B (zh) * 2020-09-16 2022-06-28 东南大学 一种针对循环肿瘤细胞的检测芯片及其检测方法
WO2022076606A1 (en) 2020-10-06 2022-04-14 Iovance Biotherapeutics, Inc. Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
EP4225330A1 (en) 2020-10-06 2023-08-16 Iovance Biotherapeutics, Inc. Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
CN112275337B (zh) * 2020-10-29 2022-03-18 上海荧辉医疗器械有限公司 一种微流控芯片及细胞筛选装置和方法
CA3201944A1 (en) 2020-11-18 2022-05-27 Cellfe, Inc. Methods and systems for mechanoporation-based payload delivery into biological cells
CA3201818A1 (en) 2020-12-11 2022-06-16 Maria Fardis Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with braf inhibitors and/or mek inhibitors
US20240123067A1 (en) 2020-12-17 2024-04-18 Iovance Biotherapeutics, Inc. Treatment of cancers with tumor infiltrating lymphocyte therapies
CA3202483A1 (en) 2020-12-17 2022-06-23 Maria Fardis Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
US12227729B2 (en) 2020-12-24 2025-02-18 Cellfe, Inc. Methods and systems for high-throughput cell processing
CN116847880A (zh) 2020-12-29 2023-10-03 Sqz生物技术公司 活化抗原载体的调配物
WO2022147026A1 (en) 2020-12-29 2022-07-07 Sqz Biotechnologies Company METHODS FOR TREATING CANCERS WITH MODIFIED PBMCs
JP2024501023A (ja) 2020-12-29 2024-01-10 スクイーズ バイオテクノロジーズ カンパニー 活性化抗原担体を用いるがんを処置するための方法
CN116670265A (zh) * 2020-12-29 2023-08-29 Sqz生物技术公司 用于扰动细胞膜的具有并行缩窄部的高通量微流控芯片
US20220203368A1 (en) 2020-12-29 2022-06-30 Sqz Biotechnologies Company Microfluidic chip having increased throughput for use in a system for delivery of a payload into a cell
WO2022147017A1 (en) 2020-12-29 2022-07-07 Sqz Biotechnologies Company Formulations for cryopreservation of pbmcs
EP4277981A1 (en) * 2021-01-13 2023-11-22 The General Hospital Corporation Viscoelastic mechanoporation systems and methods of use thereof
WO2022165260A1 (en) 2021-01-29 2022-08-04 Iovance Biotherapeutics, Inc. Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
WO2022204564A2 (en) 2021-03-25 2022-09-29 Iovance Biotherapeutics, Inc. Methods and compositions for t-cell coculture potency assays and use with cell therapy products
WO2022207717A1 (en) 2021-04-01 2022-10-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Multistage device and method for intracellular delivery
US20240182851A1 (en) * 2021-04-02 2024-06-06 Sqz Biotechnologies Company Reprogramming of cells and uses thereof
US20240158729A1 (en) * 2021-04-12 2024-05-16 MxT Biotech Intracellular delivery platform
KR20240037185A (ko) 2021-04-19 2024-03-21 이오반스 바이오테라퓨틱스, 인크. 키메라 공동자극 수용체, 케모카인 수용체, 및 세포 면역치료에서의 이의 용도
WO2022240846A1 (en) 2021-05-10 2022-11-17 Sqz Biotechnologies Company Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof
US20250127809A1 (en) 2021-06-23 2025-04-24 Novartis Ag Compositions and methods for the treatment of hemoglobinopathies
JP2024526898A (ja) 2021-07-22 2024-07-19 アイオバンス バイオセラピューティクス，インコーポレイテッド 固形腫瘍断片の凍結保存のための方法
WO2023009716A1 (en) 2021-07-28 2023-02-02 Iovance Biotherapeutics, Inc. Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors
WO2023010090A1 (en) 2021-07-29 2023-02-02 Sqz Biotechnologies Company Methods to generate enhanced tumor infiltrating lymphocytes through microfluidic delivery
CN113862112B (zh) * 2021-09-03 2023-08-15 南昌大学 微流控离心式挤压的细胞转染系统及细胞转染方法
US20230130686A1 (en) * 2021-10-25 2023-04-27 Massachusetts Institute Of Technology Devices and systems for delivery of materials to cells
CA3235824A1 (en) 2021-10-27 2023-05-04 Frederick G. Vogt Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy
US20250032618A1 (en) 2021-11-10 2025-01-30 Iovance Biotherapeutics, Inc. Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes
CN118510888A (zh) 2021-11-11 2024-08-16 加拿大干细胞技术公司 通过微流体递送来产生增强的肿瘤浸润性淋巴细胞的方法
CN114181825B (zh) * 2021-11-29 2024-05-03 南昌大学 一种外加电场作用下微流控离心式挤压的细胞转染系统
DE102021214276A1 (de) * 2021-12-14 2023-06-15 Robert Bosch Gesellschaft mit beschränkter Haftung Vorrichtung und Verfahren zum Splitten dreidimensionaler Agglomerate
EP4460370A1 (en) 2022-01-05 2024-11-13 Stemcell Technologies Canada Inc. Modified hematopoietic stem cells and uses thereof
CN114316950B (zh) * 2022-01-12 2022-08-26 广东粤港澳大湾区国家纳米科技创新研究院 通过前体胶囊制备量子点材料的方法和量子点材料、量子点组合物以及量子点器件
WO2023147488A1 (en) 2022-01-28 2023-08-03 Iovance Biotherapeutics, Inc. Cytokine associated tumor infiltrating lymphocytes compositions and methods
US20250101380A1 (en) 2022-01-28 2025-03-27 Iovance Biotherapeutics, Inc. Tumor infiltrating lymphocytes engineered to express payloads
US20250163371A1 (en) 2022-02-23 2025-05-22 Stemcell Technologies Canada Inc. Methods of producing glial cells and uses thereof
CA3247638A1 (en) 2022-04-06 2023-10-12 Maria Fardis TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA (NSCLC) WITH TUMOR-INFILTRATING LYMPHOCYTE THERAPIES
WO2023201369A1 (en) 2022-04-15 2023-10-19 Iovance Biotherapeutics, Inc. Til expansion processes using specific cytokine combinations and/or akti treatment
US20250281537A1 (en) 2022-05-10 2025-09-11 Iovance Biotherapeutics, Inc. Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with an il-15r agonist
WO2023230141A1 (en) 2022-05-24 2023-11-30 Sqz Biotechnologies Company Reprogramming of cells with self-amplifying rna
KR20250016186A (ko) 2022-05-27 2025-02-03 스템셀 테크놀러지스 캐나다 인크. 세포 내로 페이로드의 전달을 위한 시스템에서 사용하기 위한 카트리지 및 디바이스
EP4299739A1 (en) 2022-06-30 2024-01-03 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024005864A1 (en) 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
EP4299733A1 (en) 2022-06-30 2024-01-03 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
WO2024005863A1 (en) 2022-06-30 2024-01-04 Inari Agriculture Technology, Inc. Compositions, systems, and methods for genome editing
CN119866224A (zh) 2022-07-28 2025-04-22 加拿大干细胞技术公司 编码连接抗原的多核苷酸以及其用途
EP4561615A2 (en) 2022-07-28 2025-06-04 Stemcell Technologies Canada Inc. Enhanced antigen presenting cell formulations
CA3262756A1 (en) 2022-07-28 2024-02-01 Stemcell Technologies Canada Inc. CANCER TREATMENT METHODS WITH ENHANCED ANTIGEN-PRESENTING CELLS
EP4565683A1 (en) 2022-08-01 2025-06-11 Iovance Biotherapeutics, Inc. Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies
WO2024068996A1 (en) 2022-09-30 2024-04-04 Centre Hospitalier Universitaire Vaudois (C.H.U.V.) Anti-sars-cov-2 antibodies and use thereof in the treatment of sars-cov-2 infection
WO2024098024A1 (en) 2022-11-04 2024-05-10 Iovance Biotherapeutics, Inc. Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
KR20250122544A (ko) 2022-11-21 2025-08-13 이오반스 바이오테라퓨틱스, 인크. 종양 침윤 림프구의 확장을 위한 2차원 공정 및 이를 통한 요법
WO2024118836A1 (en) 2022-11-30 2024-06-06 Iovance Biotherapeutics, Inc. Processes for production of tumor infiltrating lymphocytes with shortened rep step
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
CN121443140A (zh) 2023-04-21 2026-01-30 非营利性组织佛兰芒综合大学生物技术研究所 用于作物产量提升的等位基因组合
WO2024243578A1 (en) 2023-05-25 2024-11-28 Dispatch Biotherapeutics, Inc. Synthetic cancer antigens as targets for treating cancers
WO2025007073A2 (en) 2023-06-29 2025-01-02 Dispatch Biotherapeutics, Inc. Synthetic cytokine receptors
KR20260053029A (ko) 2023-08-18 2026-04-20 에디진 바이오테크놀로지 인크. 생체내 반감기가 연장된 조작된 t 세포 및 그 제조 방법
EP4554371A4 (en) 2023-10-03 2026-04-22 Inari Agriculture Tech Inc GRNA VIRAL ADMINISTRATION IN GRAFTS
WO2025101484A1 (en) 2023-11-06 2025-05-15 Iovance Biotherapeutics, Inc. Treatment of endometrial cancers with tumor infiltrating lymphocyte therapies
WO2025168705A1 (en) 2024-02-08 2025-08-14 Vib Vzw Means and methods for the production of saponins with endosomal escape-enhancing properties
WO2025171388A1 (en) 2024-02-09 2025-08-14 Dispatch Biotherapeutics, Inc. Engineered cancer antigens with modified domains and related methods and uses
WO2025171383A2 (en) 2024-02-09 2025-08-14 Dispatch Biotherapeutics, Inc. Engineered cancer antigens and related methods and uses
WO2025240518A1 (en) 2024-05-14 2025-11-20 Dispatch Biotherapeutics, Inc. Modified lentiviral transfer plasmids
WO2026006767A1 (en) 2024-06-28 2026-01-02 Dispatch Biotherapeutics, Inc. Tethered il-9/il-9r and related engineered cells and methods

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502621C3 (de) * 1975-01-23 1978-09-14 Kernforschungsanlage Juelich Gmbh, 5170 Juelich Messung elastischer und dielektrischer Eigenschaften der Membran lebender Zellen
US4478824A (en) 1983-08-08 1984-10-23 Franco Robert S Method for altering red blood cell function and survival
FR2569477B1 (fr) 1984-08-24 1987-01-02 Descartes Universite Rene Appareil et procede pour la determination de la deformabilite des globules rouges du sang
JP2720161B2 (ja) 1988-02-01 1998-02-25 株式会社アドバンス 細胞変形能測定装置
JP2685544B2 (ja) * 1988-11-11 1997-12-03 株式会社日立製作所 血液フィルタおよび血液検査方法並びに血液検査装置
JP2532707B2 (ja) 1990-03-08 1996-09-11 佑二 菊池 血液回路及びこれを用いた血液測定装置及び血液測定方法
US5643577A (en) 1990-04-24 1997-07-01 The University Of Newcastle Research Associates Limited Oral vaccine comprising antigen surface-associated with red blood cells
US5658892A (en) 1993-01-15 1997-08-19 The General Hospital Corporation Compound delivery using high-pressure impulse transients
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
EP0814838B1 (en) 1995-03-08 2003-05-14 The Scripps Research Institute Antigen presenting system and activation of t-cells
US6051409A (en) 1995-09-25 2000-04-18 Novartis Finance Corporation Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells
DE69626853T2 (de) 1995-12-04 2004-02-19 Puget Sound Blood Center And Programm, Seattle Nicht-immunogene Blutplättchen und rote Blutzellen enthaltende Zubereitungen
BR9708387A (pt) 1996-03-28 2000-01-04 Genitrix Llc Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
DE69732225T2 (de) 1997-05-05 2005-06-23 Dideco S.R.L., Mirandola Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
US5842787A (en) 1997-10-09 1998-12-01 Caliper Technologies Corporation Microfluidic systems incorporating varied channel dimensions
SE9704076D0 (sv) 1997-11-06 1997-11-06 Holdingbolaget Vid Goeteborgs Method for permeabilisation of cell structures and use thereof
GB9816583D0 (en) 1998-07-31 1998-09-30 Univ Ulster Nucleic acid carrier
WO2000078920A1 (en) 1999-06-21 2000-12-28 The General Hospital Corporation Methods and devices for cell culturing and organ assist systems
JP2002325572A (ja) 2000-12-25 2002-11-12 Univ Osaka 外来物質の導入方法
WO2002067863A2 (en) 2001-02-22 2002-09-06 The Scepens Eye Research Institute, Inc. Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions
WO2003020039A1 (en) 2001-08-28 2003-03-13 Rush-Presbyterian-St. Luke's Medical Center Immune tolerance to predetermined antigens
AU2002353741A1 (en) 2001-11-27 2003-06-10 Cellectricon Ab A method for combined sequential agent delivery and electroporation for cell structures and use thereof
US20030133922A1 (en) 2002-01-15 2003-07-17 Kasha John R. Oral tolerance using allogeneic platelets in ITP
EP1411351A4 (en) * 2002-06-05 2010-07-07 Panasonic Corp DEVICE FOR MEASURING THE EXTRACELLULAR POTENTIAL AND METHOD FOR PRODUCING THE DEVICE
GB0214528D0 (en) 2002-06-24 2002-08-07 Univ Aberdeen Materials and methods for induction of immune tolerance
WO2004063342A2 (en) 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
US20060134067A1 (en) * 2003-02-18 2006-06-22 Maxcyte, Inc. Loading of cells with antigens by electroporation
US7968335B2 (en) * 2004-06-17 2011-06-28 Ken Nakata Cell culturing method using biomechanical stimulation loading and system therefor
EP1771608B1 (en) 2004-07-27 2010-09-15 DSM IP Assets B.V. Process for making a carbon nanotubes/ultra-high molar mass polyethylene composite fibre
US20060134772A1 (en) * 2004-11-18 2006-06-22 The Regents Of The University Of California System for locating cells and for cellular analysis
WO2006095330A2 (en) 2005-03-10 2006-09-14 Yeda Research And Development Co. Ltd. Methods and immunogenic cell preparations for treating antigen-associated diseases
US7704743B2 (en) 2005-03-30 2010-04-27 Georgia Tech Research Corporation Electrosonic cell manipulation device and method of use thereof
US7993821B2 (en) 2005-08-11 2011-08-09 University Of Washington Methods and apparatus for the isolation and enrichment of circulating tumor cells
WO2007067032A1 (en) 2005-12-09 2007-06-14 Academisch Medisch Cemtrum Bij De Universiteit Van Amsterdam Means and methods for influencing the stability of cells
WO2007097934A2 (en) 2006-02-17 2007-08-30 Elusys Therapeutics, Inc. Methods and compositions for using erythrocytes as carriers for delivery of drugs
US8293524B2 (en) * 2006-03-31 2012-10-23 Fluxion Biosciences Inc. Methods and apparatus for the manipulation of particle suspensions and testing thereof
US20070249038A1 (en) * 2006-04-21 2007-10-25 Andrea Adamo Microfluidic device for single cell targeted operations
EP2054499A2 (en) 2006-08-17 2009-05-06 Massachusetts Institute of Technology Method and apparatus for microfluidic injection
US20080311140A1 (en) 2007-05-29 2008-12-18 Baylor College Of Medicine Antigen specific immunosuppression by dendritic cell therapy
US8841135B2 (en) 2007-06-20 2014-09-23 University Of Washington Biochip for high-throughput screening of circulating tumor cells
WO2008156021A1 (ja) 2007-06-21 2008-12-24 National University Corporation Nagoya University 細胞壁を備える細胞に外来物質を導入する方法
FR2919804B1 (fr) 2007-08-08 2010-08-27 Erytech Pharma Composition et vaccin therapeutique anti-tumoral
GB0718160D0 (en) 2007-09-18 2007-10-24 Medical Res Council Methods
EP2057998A1 (en) 2007-10-31 2009-05-13 Universitätsklinikum Hamburg-Eppendorf Use of modified cells for the treatment of multiple sclerosis
EP2216639A4 (en) 2007-11-28 2014-01-15 Konica Minolta Opto Inc APPARATUS AND METHOD FOR MEASURING BLOOD FLUIDITY
US20090280518A1 (en) * 2008-05-12 2009-11-12 Massachusetts Institute Of Technology System for high throughput measurement of mechanical properties of cells
JP2010002582A (ja) 2008-06-19 2010-01-07 Konica Minolta Business Technologies Inc 画像形成装置
WO2010010513A2 (en) 2008-07-21 2010-01-28 Trium Investments (Pty) Limited Solar panel mounting arrangement
JP5137129B2 (ja) 2008-07-23 2013-02-06 国立大学法人山口大学 血液細胞の力学的特性測定装置
US9115340B2 (en) * 2008-08-08 2015-08-25 Agency For Science Technology & Research Microfluidic continuous flow device
US8211656B2 (en) 2008-08-13 2012-07-03 The Invention Science Fund I, Llc Biological targeting compositions and methods of using the same
US20110091973A1 (en) 2008-12-09 2011-04-21 Glaser Larry F Modified and fusion enhanced erythrocytes, cells and uses thereof
US9157550B2 (en) 2009-01-05 2015-10-13 The Board Of Trustees Of The University Of Illinois Microfluidic systems and methods
US9017991B2 (en) 2009-03-13 2015-04-28 Tufts University Methods tip assemblies and kits for introducing material into cells
EP2405959A4 (en) 2009-03-13 2013-10-16 Univ Tufts METHODS, DEVICES AND KITS FOR INTRODUCING GENETIC MATERIAL IN LIVING CELLS
SG174373A1 (en) 2009-03-20 2011-10-28 Agency Science Tech & Res Devices for separating cells and methods of using them
WO2010129671A2 (en) 2009-05-08 2010-11-11 Chauncey Sayre Method of and apparatus for changing one type of cell into another type of cell
GB0909754D0 (en) 2009-06-05 2009-07-22 Magnani Mauro Drug delivery systems
EP2451475A2 (en) 2009-07-06 2012-05-16 Novartis AG Self replicating rna molecules and uses thereof
US9364831B2 (en) 2009-08-08 2016-06-14 The Regents Of The University Of California Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting
WO2011051346A1 (en) 2009-10-27 2011-05-05 Erytech Pharma Composition to induce specific immune tolerance
AU2010335107B2 (en) 2009-12-21 2014-07-03 Keygene N.V. Improved techniques for transfecting protoplasts
US9005579B2 (en) 2010-01-05 2015-04-14 Contrafect Corporation Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria
US8844570B2 (en) 2010-02-01 2014-09-30 California Institute Of Technology Generating binary states using a microfluidic channel
JP5704590B2 (ja) 2010-02-05 2015-04-22 国立大学法人東京農工大学 サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出
US20120064505A1 (en) 2010-03-22 2012-03-15 Massachusetts Institute Of Technology Measurement of material properties and related methods and compositions
WO2015061458A1 (en) 2013-10-22 2015-04-30 Cellanyx Diagnostics, Inc. Systems, devices and methods for microfluidic culturing, manipulation and analysis of tissues and cells
US20140034556A1 (en) 2011-01-19 2014-02-06 The University Of British Columbia Apparatus and method for particle separation
EP2681306B1 (en) 2011-02-28 2019-01-09 President and Fellows of Harvard College Cell culture system
WO2012162779A1 (en) 2011-05-27 2012-12-06 The University Of British Columbia Microfluidic cell trap and assay apparatus for high-throughput analysis
MX2013013243A (es) 2011-07-05 2014-05-30 Sotio As Medios y metodos para activar la inmunoterapia celular del cancer utilizando celulas cancerosas destruidas mediante presion hidrostatica y celulas dendriticas.
US20130065314A1 (en) 2011-08-25 2013-03-14 Phytocentric Biotech Inc. Algal transformation systems, compositions and methods
ES2764105T3 (es) * 2011-10-17 2020-06-02 Massachusetts Inst Technology Administración intracelular
WO2013185032A1 (en) 2012-06-07 2013-12-12 President And Fellows Of Harvard College Nanotherapeutics for drug targeting
US9255245B2 (en) 2012-07-03 2016-02-09 Agilent Technologies, Inc. Sample probes and methods for sampling intracellular material
CN102925337B (zh) 2012-11-08 2014-06-18 武汉友芝友生物制药有限公司 一种微流体细胞捕获芯片及其制备方法
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
GB201300049D0 (en) 2013-01-03 2013-02-20 Transimmune Ag Method for obtaining immuno-stimulatory dendritic cells
GB201300052D0 (en) 2013-01-03 2013-02-20 Transimmune Ag Method for obtaining immuno-suppressive dendritic cells
US20140295490A1 (en) 2013-01-30 2014-10-02 Asta Fluidic Technologies, Inc. Fetal red blood cell detection
US9725709B2 (en) 2013-03-12 2017-08-08 OpenCell Technologies, Inc. Intracellular delivery and transfection methods and devices
JP6606058B2 (ja) 2013-03-15 2019-11-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 光熱プラットフォームを使用する生細胞への高スループットカーゴ送達
KR20140115560A (ko) 2013-03-21 2014-10-01 인하대학교 산학협력단 기계적 스트레스를 이용한 단세포 생물체 개질 방법 및 이에 사용되는 장치
WO2014165707A2 (en) 2013-04-03 2014-10-09 Memorial Sloan-Kettering Cancer Center Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
SG10201801188XA (en) 2013-08-16 2018-03-28 Massachusetts Inst Technology Selective delivery of material to cells
US10137673B2 (en) 2013-12-31 2018-11-27 Canon U.S. Life Sciences, Inc. Methods and systems for continuous flow cell lysis in a microfluidic device
EP3583946A1 (en) 2014-04-01 2019-12-25 Rubius Therapeutics, Inc. Enucleated hematopoietic cells comprising an exogenous antigen
KR102595473B1 (ko) 2014-04-18 2023-10-30 에디타스 메디신, 인코포레이티드 암 면역요법을 위한 crispr-cas-관련 방법, 조성물 및 구성성분
EP3164482B1 (en) 2014-07-03 2024-05-22 Massachusetts Institute of Technology Apparatus and method for optimization of cell electroporation
RU2739794C2 (ru) 2014-10-31 2020-12-28 Массачусетс Инститьют Оф Текнолоджи Доставка биомолекул в клетки иммунной системы
JP6846345B2 (ja) 2014-11-14 2021-03-24 マサチューセッツ インスティテュート オブ テクノロジー 破壊及び場による細胞への化合物及び組成物の送達
US9744533B2 (en) 2014-12-10 2017-08-29 Berkeley Lights, Inc. Movement and selection of micro-objects in a microfluidic apparatus
HK1247241A1 (zh) 2015-01-07 2018-09-21 英迪公司 一种用於机械和水动力微流体转染的方法以及用於其的设备
AU2016206870B2 (en) 2015-01-12 2022-02-17 Massachusetts Institute Of Technology Gene editing through microfluidic delivery
WO2016183482A1 (en) 2015-05-13 2016-11-17 Rubius Therapeutics, Inc. Membrane-receiver complex therapeutics
GB201513278D0 (en) 2015-07-03 2015-09-09 Transimmune Ag And Yale University Device and method for obtaining immunostimulatory antigen-presenting cells
AU2016289530B2 (en) 2015-07-09 2021-05-06 Massachusetts Institute Of Technology Delivery of materials to anucleate cells
WO2017041051A1 (en) 2015-09-04 2017-03-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to cells comprising a cell wall
JP7046795B2 (ja) 2015-09-04 2022-04-04 スクイーズ バイオテクノロジーズ カンパニー 細孔を有する表面によって媒介される生体分子の細胞内送達
CA3009369A1 (en) 2015-12-22 2017-06-29 Sangui Bio Pty. Ltd Therapeutic methods using erythrocytes
PT3402491T (pt) 2016-01-11 2022-03-03 Rubius Therapeutics Inc Composições e métodos relacionados com sistemas celulares terapêuticos multimodais para indicações de cancro
CN108779475A (zh) 2016-01-12 2018-11-09 Sqz生物技术公司 复合物的细胞内递送
RU2747878C2 (ru) 2016-05-03 2021-05-17 ЭсКьюЗед БАЙОТЕКНОЛОДЖИЗ КОМПАНИ Внутриклеточная доставка биомолекул для индукции толерантности
RU2770492C2 (ru) 2016-05-03 2022-04-18 ЭсКьюЗед БАЙОТЕКНОЛОДЖИЗ КОМПАНИ Внутриклеточная доставка биологических молекул для индуцирования толерантности
US20170326213A1 (en) 2016-05-16 2017-11-16 Augusta University Research Institute, Inc. Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
CN106244543A (zh) 2016-07-29 2016-12-21 北京时合生物科技有限公司 一种pbmc体外诱导分化成为树突状细胞的方法
WO2018089497A1 (en) 2016-11-08 2018-05-17 Georgia Tech Research Corporation Methods for convectively-driven intracellular delivery
US12440839B2 (en) * 2018-08-21 2025-10-14 The Regents Of The University Of California High-throughput system and method for the temporary permeabilization of cells using lipid bilayers
AU2020380721B2 (en) * 2019-11-06 2023-11-09 Korea University Research And Business Foundation Droplet deformation-based method of transferring material into cells and chip for same
EP4277981A1 (en) * 2021-01-13 2023-11-22 The General Hospital Corporation Viscoelastic mechanoporation systems and methods of use thereof
WO2022207717A1 (en) * 2021-04-01 2022-10-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Multistage device and method for intracellular delivery
EP4324926A4 (en) * 2021-04-12 2026-04-22 MxT Biotech INTRACELLULAR DISTRIBUTION PLATFORM

Also Published As

Publication number Publication date
AU2012326203A1 (en) 2014-05-15
RS59898B1 (sr) 2020-03-31
RU2014119926A (ru) 2015-11-27
US20200277566A1 (en) 2020-09-03
AU2012326203B2 (en) 2017-11-30
HRP20200051T1 (hr) 2020-03-20
US20190093073A1 (en) 2019-03-28
LT2768942T (lt) 2020-04-10
CA2852672A1 (en) 2013-04-25
EP2768942A4 (en) 2015-05-27
CN113337402A (zh) 2021-09-03
US20140287509A1 (en) 2014-09-25
US10696944B2 (en) 2020-06-30
WO2013059343A1 (en) 2013-04-25
SI2768942T1 (sl) 2020-03-31
CN107058101A (zh) 2017-08-18
CN107058101B (zh) 2021-06-01
CN103987836A (zh) 2014-08-13
CN103987836B (zh) 2018-04-10
CN113337402B (zh) 2024-11-29
AU2012326203A2 (en) 2014-05-22
EP2768942A1 (en) 2014-08-27
EP3608394A1 (en) 2020-02-12
KR20140116374A (ko) 2014-10-02
BR112014009346A2 (pt) 2017-04-18
BR112014009346B1 (pt) 2020-09-15
PT2768942T (pt) 2020-01-21
JP2014533936A (ja) 2014-12-18
JP2018023395A (ja) 2018-02-15
EP2768942B1 (en) 2019-12-04
CA2852672C (en) 2021-07-20
DK2768942T3 (da) 2020-01-27
JP6629272B2 (ja) 2020-01-15
ES2764105T3 (es) 2020-06-02
HUE047507T2 (hu) 2020-04-28
JP6219832B2 (ja) 2017-10-25
RU2656156C2 (ru) 2018-05-31
KR102058568B1 (ko) 2020-01-22

Similar Documents

Publication Publication Date Title
SI2768942T1 (sl) Znotrajcelično dovajanje
PL3313083T3 (pl) Dostarczanie treści segmentowanej przestrzennie
EP2683328A4 (en) RELEASE SYSTEM
HUE041889T2 (hu) Releváns tartalom kézbesítése
GB201121069D0 (en) Delivery system
GB201101870D0 (en) Pump
IL231966A (en) Pumps
EP2694398A4 (en) DISTRIBUTOR
EP2802776A4 (en) PUMP
IL232066A0 (en) Divide
GB201301300D0 (en) No details
GB201114794D0 (en) Dispenser
EP2698053A4 (en) MOWING MACHINE
EP2741987A4 (en) DISTRIBUTOR
GB201111944D0 (en) Delivery drop box
EP2750569A4 (en) DONOR
GB201111313D0 (en) Flavour delivery
GB201107503D0 (en) Delivery device
AU342748S (en) Dispenser
GB201117255D0 (en) Dispenser
GB201103084D0 (en) Dispenser
PH32011000369S1 (en) Dispenser
GB201200661D0 (en) Delivery vesicles
GB201200258D0 (en) Dispensers
GB201114410D0 (en) Dispensing aid